My Watchlist for Thursday, November 03

( click to enlarge )
Atara Biotherapeutics Inc (NASDAQ:ATRA) broke out of the descending channel pattern today with impressive gains of 3.3%, outperforming the entire sector. Daily RSI and MACD indicators are also starting to turn up from low levels. Watch for continuation.

( click to enlarge )
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a stock that deserves some attention over the coming sessions, for a potential short-term reversal.

( click to enlarge )
Melco Crown Entertainment Ltd (ADR) (NASDAQ:MPEL) Bullish rally stalled by resistance and market weakness. After setting a new month-high today, the stock has encountered resistance around the $18.40 area, a level which it should be able to beat given the cuurent strong upward trend. Keep your eyes on this one. Hot sector.

( click to enlarge )
Adverum Biotechnologies Inc (NASDAQ:ADVM) looks like it may have found a bottom already. Go long on the break of Wednesday’s high at 3.10 with a tight stop at 2.85

( click to enlarge )
Medovex Corp.(NASDAQ:MDVX) could be in the early stages of a technical breakout. A break through today's high on volume could lead this stock to 1.98/2 short-term.

If you want to contact me for advertising opportunities on blog or twitter, then get in touch via email

Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.

Thanks for visiting AC Investor Blog.

AC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.